PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
PharmAla Biotech Holdings Inc. has announced a private placement offering aimed at raising $750,000 by selling units at $0.18 each, primarily to committed long-term shareholders. The proceeds are intended for securing global patent rights, manufacturing, clinical trials, and general corporate needs. Additionally, the company plans to settle a $108,000 debt with consultant Aaron Logan by issuing him 600,000 common shares.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.
